NITROPRESS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nitropress, and when can generic versions of Nitropress launch?
Nitropress is a drug marketed by Abbott, Abbvie, Hospira, and Vpna. and is included in four NDAs.
The generic ingredient in NITROPRESS is sodium nitroprusside. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nitropress
A generic version of NITROPRESS was approved as sodium nitroprusside by SAGENT PHARMS INC on December 8th, 2016.
Summary for NITROPRESS
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Clinical Trials: | 4 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NITROPRESS |
| DailyMed Link: | NITROPRESS at DailyMed |
Recent Clinical Trials for NITROPRESS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| American Heart Association | Phase 2 |
| Massachusetts General Hospital | Phase 2 |
| Stanley Medical Research Institute | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for NITROPRESS
US Patents and Regulatory Information for NITROPRESS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | NITROPRESS | sodium nitroprusside | INJECTABLE;INJECTION | 071555-001 | Nov 16, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Vpna | NITROPRESS | sodium nitroprusside | INJECTABLE;INJECTION | 071961-001 | Aug 1, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Abbvie | NITROPRESS | sodium nitroprusside | INJECTABLE;INJECTION | 018450-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
